24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
(361)575-0611
(800)421-8825
Fax: (361)578-5500

Child & Adolescent Development: Overview
Resources
Basic InformationMore InformationLatest News
For Kids Born With HIV, Taking Needed Meds Gets Harder With Age: StudyBuilding a Better BackpackKids Getting Too Many Opioids After TonsillectomyExplaining, Easing the Horror of Mass Shootings for Your KidsFor Kids With Asthma, Allergies, New School Year Can Bring Flare-UpsAnother Video Game Risk to Watch Out ForOlder Parents May Have Better Behaved KidsAre Too Many Kids Prescribed Antihistamines?Childhood Cancer Steals Over 11 Million Years of Healthy Life: StudyFamily Home, Football Field Most Dangerous Spots for Kids' Head InjuriesMost Airplanes Not Equipped With First Aid for KidsPlastics Chemicals Meant to Replace BPA May Not Be Any Safer for KidsWhat Happens to the Children When Parents Fight?Health Tip: Giving Medicine Safely to ChildrenHow to Make Your Child's Hospital Stay Safer, Less StressfulObesity May Boost Odds for MS in KidsHealth Tip: Diarrhea in KidsOpioid Epidemic Doubled Number of U.S. Kids Sent to Foster CareSwimming Lessons a Must for EveryoneHow to Help When Your Child Weighs Too MuchHave Kids, Buy More Produce?Zika's Damage Continues in Children Infected Before BirthCDC Warns of Start to 'Season' for Mysterious Paralyzing Illness in KidsParent Who Listens Can Help Kids Thrive Despite TraumaHealth Tip: Ear Piercing For KidsReacting Against a 'Too Clean' World, Some Parents Go Too Far the Other WaySurvey Urges Grandparents to Lock Down Their Meds When Kids VisitCalifornia Took on Anti-Vaxxers, and WonHow Does Sunshine During Pregnancy Affect Learning?Surgery Helps Babies Missing a Heart Chamber Survive, But Problems LingerAbuse, Injury More Likely When Child is With Male Caregiver: StudyHow to Foster Your Child's ImaginationLow Vitamin D at Birth Linked to Kids' High Blood Pressure RiskHow Do Kids Learn To Turn Off Troublesome Tics?Meet 'Huggable,' the Robot Bear Who's Helping Hospitalized KidsWill Video Games Make Your Kid Obese? Maybe NotChildhood Brain Tumor Survivors Face More StrugglesFDA Expands Cystic Fibrosis Treatment Approval to Children Ages 6 to 12New Drug Combats Leading Cause of DwarfismHow Do Birth Defects Affect Childhood Cancer Risk?FDA Approves Victoza Injection for Children 10 Years and OlderHealth Tip: Preparing Your Child For Sleepaway CampTips for Keeping Your Child Healthy at CampA Simple Way to Help Prevent Child ObesityType 1 Diabetes Might Affect Young Kids' Brain DevelopmentHow to Put Limits on Your Family's Screen TimeChickenpox Vaccine Shields Kids From Shingles, TooWhooping Cough Vaccine Effectiveness Fades With Time: StudyHundreds of Young Kids Drown in Pools Each Year -- Keep Yours SafeWhich Dogs Are More Likely to Bite Your Kids?
Questions and AnswersLinks
Related Topics

ADHD: Attention Deficit Hyperactivity Disorder
Childhood Mental Disorders and Illnesses
Child Development & Parenting: Infants (0-2)
Child Development & Parenting: Early (3-7)

Newer Diabetes Drug Shows Promise in Kids, Teens

HealthDay News
by -- Robert Preidt
Updated: Apr 30th 2019

new article illustration

TUESDAY, April 30, 2019 (HealthDay News) -- A type 2 diabetes drug for adults also controls blood sugar levels in children and teens with the disease, researchers report.

Type 2 diabetes is on the rise among children and teens, but they have fewer treatment choices than adults, the study authors said. Currently, the only drugs approved for treatment of children and teens with type 2 diabetes are metformin and insulin.

This study, led by researchers at Yale University, looked at how the drug liraglutide (Victoza) affected blood sugar and glycated hemoglobin (or A1c) levels in patients aged 10 to 16 with type 2 diabetes who were already taking metformin with or without insulin.

Half of the patients took metformin plus liraglutide, and the other half took metformin plus an inactive placebo. The participants' blood sugar and A1c levels were checked after six months and one year.

For those with type 2 diabetes, an A1c level below 7% means their diabetes is relatively well-controlled, the study authors noted.

After six months, those in the liraglutide group had substantially lower blood sugar levels and their A1c levels were 1.1 percentage points lower than those in the placebo group, the findings showed.

After one year, the liraglutide group had A1c levels 1.3 percentage points lower than the placebo group, which had an average 0.5 percentage point increase.

The investigators also found that, after one year, nearly two-thirds of the liraglutide group had A1c levels under the 7% target, compared to one-third of the placebo group.

The study, published online April 28 in the New England Journal of Medicine, was funded by the drug's maker, Novo Nordisk.

The findings could be "transformational" for children and teens with type 2 diabetes, according to study first author Dr. William Tamborlane, a pediatric endocrinologist at Yale.

Metformin is the most popular initial treatment for type 2 diabetes in children and teens, but it often leads to an early loss of blood sugar control, and add-on treatment with insulin usually fails to lower blood sugar levels, the researchers explained in a university news release.

"As a result of this study, we anticipate that youth with type 2 diabetes will soon have a third option that has not previously been available," Tamborlane said.

More information

The U.S. Centers for Disease Control and Prevention explains how to prevent type 2 diabetes in children.